Home LiteratureArticle Details

PMID: 6361173 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Review

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

The Journal of infectious diseases ·Vol. 148 ·No. 6 ·1983-12-00 ·Pages 1136-59

Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Mäkelä PH, Broome CV, Facklam RR, Tiesjema RH

Abstract

暂无摘要

MeSH Terms

ABO Blood-Group System/immunology Adult Animals Antibodies, Bacterial/analysis Bacterial Vaccines/administration & dosage,immunology Child Cross Reactions Humans Infant Meningitis, Pneumococcal/microbiology Opsonin Proteins Phagocytosis Pneumococcal Infections/microbiology,prevention & control Pneumococcal Vaccines Polysaccharides, Bacterial/classification,immunology Species Specificity Streptococcus pneumoniae/classification,immunology Vaccination

Chemicals

ABO Blood-Group System Antibodies, Bacterial Bacterial Vaccines Opsonin Proteins Pneumococcal Vaccines Polysaccharides, Bacterial

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

Robbins J B

Austrian R

Lee C J

Rastogi S C

Schiffman G

Henrichsen J

Mäkelä P H

Broome C V

Facklam R R

Tiesjema R H

Article Info

Journal

The Journal of infectious diseases

Abbr.

J Infect Dis

ISSN

0022-1899

DOI

10.1093/infdis/148.6.1136

Published

1983-12-00

Pages

1136-59

Language

English

Region

United States

NLM ID

0413675

Subset

External Links

PubMed source DOI: 10.1093/infdis/148.6.1136 View journal details

Analysis Services

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Contact

WeChat Official Account